Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-27T19:13:17.586Z Has data issue: false hasContentIssue false
  • English
  • Français

Malignant Thymoma Presenting as Sensorineural Deafness

Published online by Cambridge University Press:  02 December 2014

Gary Hunter ,
Jennifer Ringrose  and
Andrew Kirk
Gary Hunter
Affiliation:
Department of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Jennifer Ringrose
Affiliation:
Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Andrew Kirk
Affiliation:
Department of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Peer Reviewed Letter
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 2 , May 2008 , pp. 265 - 266
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Souadjian, JV, Enriquez, P, Silverstein, MN, Pepin, JM. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med. 1974 Aug; 134(2):374-9.Google Scholar
2. Goulon, M, Estournet, B, Tulliez, M. Myasthenia gravis and associated diseases. Int J Neurol. 1980; 14(1):61–72.Google Scholar
3. Vernino, S, Auger, RG, Emslie-Smith, AM, Harper, CM, Lennon, VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology. 1999 Oct 12; 53(6):1233–9.Google Scholar
4. Rickman, OB, Parisi, JE, Yu, Z, Lennon, VA, Vernino, S. Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. Mayo Clin Proc. 2000 Dec; 75(12):1321–6.CrossRefGoogle ScholarPubMed
5. Vernino, S, Cheshire, WP, Lennon, VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001 May 14; 88(3):187–92.Google Scholar
6. Bozzolo, E, Bellone, M, Quaroni, N, Voci, C, Sabbadini, MG. Thymoma associated with systemic lupus erythematosus and immunologic abnormalities. Lupus. 2000; 9(2):151–4.Google Scholar
7. Vernino, S, Lennon, VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004 Nov 1; 10(21): 7270–5.Google Scholar
8. Evoli, A, Minicuci, GM, Vitaliani, R. Paraneoplastic diseases associated with thymoma. J Neurol. 2007 Jun; 254(6):756–62.Google Scholar
9. Mathews, J, Kumar, BN. Autoimmune sensorineural hearing loss. Clin Otolaryngol Allied Sci. 2003 Dec; 28(6):479–88.Google Scholar
10. Harris, JP, Sharp, PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope. 1990 May; 100(5):516–24.Google Scholar
11. Billings, PB, Keithley, EM, Harris, JP. Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol. 1995 Mar; 104(3):181–8.CrossRefGoogle Scholar
12. Trune, DR, Kempton, JB, Hefeneider, SH, Bennett, RM. Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kDa link between autoimmune disease and hearing loss. Hear Res. 1997 Mar; 105(1-2):57–64.Google Scholar
13. Luetje, CM. Theoretical and practical implications for plasma-pheresis in autoimmune inner ear disease. Laryngoscope. 1989 Nov; 99(11):1137–46.CrossRefGoogle Scholar